Chong Kun Dang Holdings Corp. (KRX:001630)
South Korea · Delayed Price · Currency is KRW 38,400
+250 (0.66%)
Aug 3, 2026, 3:30 PM KST
Chong Kun Dang Holdings Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 952,658 | 959,012 | 957,753 | 879,781 | 908,963 | 925,975 |
Revenue Growth | -0.18% | 0.13% | 8.86% | -3.21% | -1.84% | 7.91% |
Gross Profit Gross Profit Growth | 426,562 | 427,300 | 444,576 | 383,864 | 399,188 | 441,409 |
Operating Income Operating Income Growth | 65,395 | 57,638 | 35,436 | 17,005 | -32,878 | 34,411 |
Net Income Net Income Growth | 47,381 | 40,430 | 33,596 | 47,007 | 1,074 | 15,993 |
Earnings Per Share EPS Growth | 9743.12 | 8422.78 | 7057.00 | 9743.89 | 219.04 | 3211.67 |
EPS Growth | 50.93% | 19.35% | -27.57% | 4348.44% | -93.18% | -79.56% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medicine Medicine Growth | 913,345 | 925,735 | 846,810 | 897,366 | 928,415 |
Consolidation Adjustment Consolidation Adjustment Growth | -36,346 | -40,598 | -31,577 | -50,474 | -68,331 |
Other Other Growth | 82,012 | 72,616 | 64,548 | 62,071 | 65,891 |
Total Total Growth | 959,012 | 957,753 | 879,781 | 908,963 | 925,975 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 145,938 | 117,101 | 61,116 | 81,156 | 82,808 | 144,938 |
Total Debt Total Debt Growth | 567,562 | 540,810 | 479,654 | 468,034 | 429,341 | 345,321 |
Net Cash (Debt) Net Cash Growth | -421,624 | -423,709 | -418,537 | -386,878 | -346,533 | -200,383 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -86570.83 | -88118.99 | -87917.67 | -80193.67 | -70644.95 | -40239.82 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 105,334 | 76,035 | 23,966 | 37,147 | -46,502 | 40,460 |
Capital Expenditures CapEx Growth | -69,665 | -55,973 | -41,521 | -25,539 | -58,027 | -100,475 |
Free Cash Flow Free Cash Flow Growth | 35,669 | 20,062 | -17,556 | 11,608 | -104,529 | -60,015 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.78% | 44.56% | 46.42% | 43.63% | 43.92% | 47.67% |
Operating Margin | 6.87% | 6.01% | 3.70% | 1.93% | -3.62% | 3.72% |
Pretax Margin | 8.10% | 6.79% | 4.22% | 4.97% | -2.72% | 3.01% |
Profit Margin | 4.97% | 4.22% | 3.51% | 5.34% | 0.12% | 1.73% |
FCF Margin | 3.74% | 2.09% | -1.83% | 1.32% | -11.50% | -6.48% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1400.000 | 1400.000 | 1400.000 | 1400.000 | 1400.000 | 1400.000 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 3.67% | 3.11% | 3.02% | 2.50% | 2.86% | 2.03% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 3.94 | 5.45 | 6.76 | 6.01 | 240.33 | 23.72 |
Forward PE | - | 8.58 | 26.47 | 17.26 | 9.84 | 11.25 |
P/FCF Ratio | 5.13 | 10.98 | - | 24.34 | - | - |
PS Ratio | 0.19 | 0.23 | 0.24 | 0.32 | 0.28 | 0.41 |